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ABSTRACT
Enteropathy-associated T-cell Lymphoma (EATL) is a rare form of aggressive 
T-cell lymphoma. It is more prevalent in men over 60 years and the prognosis 
is very poor. EATL is classified into two groups based on morphology, 
immunohistochemistry, and genetic profile. EATL type I is highly associated 
with celiac disease and is more common in Western countries. EATL type II 
predominates over type I in Asia, where celiac disease is uncommon. We report 
a case of a 78-year-old previously healthy white male who presented with a 
2-month history of diarrhea, weight loss and edema. The abdomen was distended 
and painful, and a tumor mass was palpable in the hypogastrium. Laboratory 
tests showed hypoalbuminemia. Serological tests for HIV, viral hepatitis and 
HTLV-1 were negative. The chest radiography showed pneumoperitoneum, 
and an exploratory laparotomy revealed perforation of the small bowel. An 
advanced stage (Ann Arbor IV B/Lugano IIE2B) EATL type II was diagnosed. 
Four cycles of chemotherapy were interspersed with several complications 
(anthracycline-induced cardiotoxicity, chemotherapy-induced neutropenic 
fever and severe sepsis). Performance status progressively worsened and he 
died 6 months after the diagnosis. This is an illustrative report of a rare and 
aggressive primary intestinal lymphoma. To the best of our knowledge, this is 
the first report of EATL type II in Brazil.
Keywords: Enteropathy-Associated T-Cell Lymphoma; Celiac Disease; Lymphoma, Non-Hodgkin; 
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CASE REPORT
A 78-year-old previously healthy white 
male patient sought medical care with a 2-month 
history of diarrhea accompanied by 20 kg of weight 
loss. He denied fever or night sweats. One month 
prior the hospital admission a slight lower-limb 
edema started, which progressively worsened 
reaching the thighs. An erythematic eruption also 
appeared on the anterior surface of both legs. On 
32
Autopsy and Case Reports 2012; 2(2): 31-36 Felipe-Silva A, Campos FPF, Medeiros RSS, Lourenção RM, Zerbini MCN.
5.5 cm ulcerated, infiltrated, whitish and soft tumor 
(Figure 1). Tumor perforation was detected in one 
segment as well as suppurative serositis. Whitish 
and soft enlarged lymph nodes (up to 3.0 cm) 
adhered to the segment. Surrounding mucosa and 
bowel wall were somewhat thickened and rubbery.
On microscopic examination, tumor masses 
invaded through the wall of the intestine (Figure 2A) 
and were composed by cells with medium-sized 
round or irregular, darkly staining nuclei with a 
rim of pale or eosinophilic cytoplasm (Figure 2B). 
Frequent mitotic figures and some enlarged nucleoli 
were seen. Intestinal crypts and surface epithelium 
were diffusely infiltrated by malignant cells. Villous 
atrophy and crypt hyperplasia were also present 
(Figure 2C and 2D). Two adjacent lymph nodes were 
invaded by tumor cells. No other foci of infiltration 
were detected.
On immunohistochemistry analysis, 
neoplastic cells were CD3+, CD8+ and CD56+, 
which was consistent with a natural killer like 
(NK-like) T cell or even NK phenotype (Figure 3A 
and C). Immunostaining for CD20, CD30, ALK, CD4 
and CD5 were all negative. Proliferation index by 
Ki67 was 60-70%. Pancytokeratin immunostaining 
with AE1+AE3 highlighted villous atrophy and 
intraepithelial infiltration by both individual and 
clusters of tumor cells (Figure 3D). These findings 
were consistent with enteropathy-associated T-cell 
lymphoma type II (EATL type II).
the day of hospital admission he referred an intense 
and diffuse abdominal pain radiating to the back.
The physical examination revealed an ill-
looking, pale, and dehydrated patient. The pulse 
rate was 120 beats per minute and blood pressure 
was 90/50 mmHg. The lower limbs were edematous, 
with bullous lesions over an erythematous skin 
(consistent with erysipela) on the anterior surface of 
both legs. The heart and lungs examination 
was unremarkable. The abdomen was distended, 
painful, and a tumor mass was palpable in the 
hypogastrium. Bowel sounds were absent and the 
rebound tenderness (Bloomberg sign) was positive.
Laboratory tests are shown in Table 1. 
Serological tests for HIV, hepatitis (B and C) and 
HTLV-1 were negative.
The chest radiography showed the image 
of pneumoperitoneum. The patient underwent 
an exploratory laparotomy, which revealed a 
large amount of enteric fluid in the abdominal 
cavity and perforation of the small intestine 
at 15 cm and 220 cm from the Treitz angle. The 
two perforated segments were resected. The 
post-operative follow up was marked by generalized 
edema and hypoalbuminemia.
Gross examination of enterectomy 
specimens revealed two segments of jejunum 
(42 cm length each). Each segment presented a 
Table 1 – Laboratory work up
Exam Result RV Exam Result RV
Hemoglobin 13.2 12.3-15.3 g/dL Creatinine 1.4 0.4-1.3 mg/dL
Hematocrit 40 36.0-45.0% Urea 57 10-50 mg/dL
 Leukocytes 9.1 4.4-11.3×10³/mm³ Ionized Ca+ 1.07 1.15-1.35 Mmol/L
Promyelocytes 1 0 Sodium 138 136-146 mEq/L
Myelocytes 3 0 Potassium 5.3 3.5-5.0 mEq/L
Metamyelocytes 5 0 AST 20 10-31 IU/L
Bands 25 1-5% ALT 21 9-36 IU/L
Segmented 50 46-75% Alkaline phosphatase 83 10-100 IU/L
Eosinophils 0 1-4% γGT 46 2-30 IU/L
Basophils 0 0-2.5% Total bilirubin 0.7 0.3-1.2 mg/dL
Lymphocytes 15 18-40% Total protein 3.7 6.0-8.0 g/dL
Monocytes 1 2-9% Albumin 1.0 3.0-5.0 g/dL
Platelets 509×10³ 150-400×10³/ mm³ LDH 168 120-246 IU/L
ALT = alanine aminotransferase, AST = aspartate aminotransferase, γGT = gamma-glutamyl transferase, LDH = serum lactate dehydrogenase, RV = reference value.
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Post-operative abdominal computed 
tomography (CT) revealed the presence of confluent 
lymph nodes, near the superior mesenteric vascular 
bundle, measuring up to 2.5 cm with homogeneous 
enhancement by the contrast medium. Neck and 
chest CT did not detect lymphadenopathy.
The patient developed nosocomial 
pneumonia, which delayed the start of the specific 
treatment. After clinical improvement he was 
referred to an oncology center. Bone marrow biopsy 
revealed no lymphoma infiltration. Disease was 
staged Ann Arbor IV B/Lugano IIE2B. Treatment 
started with CHOP chemotherapy and was 
changed to COP scheme after 2 cycles. The patient 
developed anthracycline-induced cardiotoxicity, 
chemotherapy-induced neutropenic fever and 
severe sepsis. Performance status progressively 
worsened and he died 6 months after the diagnosis. 
Postmortem examination was not requested.
DISCUSSION
The gastrointestinal tract is the most common 
location of extranodal lymphomas. The stomach is 
the most frequent site of involvement (mainly due to 
Helicobacter pylori associated mucosal associated 
lymphoid tissue - MALT – lymphoma), followed 
by the small intestine.1,2 Primary large bowel and 
rectum lymphomas are much less common.3
Most gastrointestinal primary lymphomas 
are of B phenotype (MALT lymphoma, large B 
cell lymphoma, mantle cell lymphoma, follicular 
lymphoma, Burkitt lymphoma and immunoproliferative 
small intestinal disease- IPSID).4
Primary gastrointestinal tract T-cell 
lymphomas are mostly associated with malabsorption, 
as a complication of celiac sprue. These cases have 
been designated as ‘‘enteropathy-associated T-cell 
lymphoma’’ (EATL) and they are characterized by 
prominent intraepithelial lymphomatous spread and 
villous atrophy of uninvolved mucosa. T cells show 
varying degrees of transformation, frequently with 
an inflammatory background.5,6,7
EATL is considered a rare form of aggressive 
T-cell lymphoma accounting for less than 1% of 
non-Hodgkin lymphomas. The estimated annual 
incidence rate is 0.5-1 per million people in Western 
countries. It is more prevalent in men over 60 
years.8,9 The outcome is very poor with an overall 
survival rate of 15-20% in 2-year.10
Based on morphology, immunohistochemistry 
and genetic profile EATL can be divided into two 
groups. EATL type I is a large-size cell lymphoma 
which is highly associated with celiac disease and 
mostly, presents with malabsorption, weight loss 
and celiac disease-related symptoms. Geographic 
distribution follows that of celiac disease, with a high 
prevalence in Northern Europe. Most patients show 
adult onset celiac disease, sometimes with an initial 
period of refractory disease and ulcerative jejunitis. 
Tumor cells are typically CD3+, CD5–, CD7+, 
CD8+/–, CD4–, CD30+ and contain cytotoxic granule 
associated proteins by immunohistochemistry.7,11
EATL type II comprises about 10-20% of 
EATL and is composed of monomorphic, small to 
medium-sized cells. Obstruction or perforation of 
the small bowel is common. EATL type II is not 
associated with celiac disease and may occur 
sporadically. The immunophenotype is somewhat 
different from EATL type I (CD3+, CD4–, CD8+, 
CD56+).5,12,13 Prognosis of EATL type II seems to be 
even worse, with median overall survival of 7 months 
and progression-free-survival of 1 month.14
Other T-cell lymphomas may also develop in 
the intestine and sometimes simulate the histologic 
pattern of EATL.15 T-cell lymphomas can involve any 
part of the gastrointestinal tract, especially in patients 
in the Far East, where most cases are peripheral 
T-cell lymphomas, not otherwise specified (NOS), 
Figure 1 – View of a section through small bowel 
EATL type II.
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known as Mediterranean lymphoma or α heavy 
chain disease, it mainly occurs in the Middle East 
and arises in association with a morphologically 
benign-appearing infiltrate, often characterized by 
a dense, plasma cell proliferation in the intestinal 
mucosa.24
This patient did not have a history of celiac 
disease. Actually, this was a quite recent onset with 
a clinical history of 2 months, which is consistent 
with EATL type II. Despite that, the patient 
presented with severe diarrhea and malabsorption, 
hypoalbuminemia and peripheral edema. In a recent 
large multicenter analysis of 38 patients with EATL 
type II, diarrhea and hypoalbuminemia were present 
in 21% and 90% of the cases, respectively.14
In summary, this is an illustrative report of a 
rare and aggressive primary intestinal lymphoma. 
To the best of our knowledge, this is the first report 
of EATL type II in Brazil.
NK/T-cell lymphomas of nasal type, and cases 
linked with the HTLV-1 virus.16-21
NK-cell enteropathy has recently been 
described as an entity that mimics EATL, especially 
the type II. In the case series reported by Mansoor et 
al., 8 patients presented with vague gastrointestinal 
symptoms and a mucosal infiltrate of atypical cells 
with an NK-cell phenotype. No patient developed 
progressive disease or died of lymphoma. In 
contrast with EATL type II, NK-cell enteropathy cells 
are CD8- and do not show marked epitheliotropism. 
Furthermore, clonal T-cell gene rearrangement is 
absent in NK-cell enteropathy.22
Differential diagnosis could also include IPSID, 
which is an uncommon type of gastrointestinal B cell 
lymphoma that tends to manifest as malabsorption, 
presents in the duodenum or proximal jejunum, 
and exhibits villous atrophy as well as plasma 
cell infiltration of the adjacent intestine.23 Formerly 
Figure 2 – Photomicrography – small bowel surgical pathology specimen. A - (H&E, 12.5x) Tumor cells 
invade through the entire bowel wall. Serosal exudate secondary to perforation can be seen at the bottom; 
B - (H&E, 400x) Lymphoma cells with medium-sized round or irregular, darkly staining nuclei with a rim 
of pale or eosinophilic cytoplasm; C - (H&E, 100x) Villous atrophy and crypt hyperplasia; D - (H&E, 400x) 
Marked intraepithelial infiltration by lymphoma cells.
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